In the current multicentric study, we performed a survival analysis in hormone-sensitive PCa patients with PSA recurrence after RP who underwent PSMA-PET, and salvage treatments guided by PSMA imaging, evaluating the potential prognostic role of PSMA-PET. This evidence concerns the gene FOLH1 and posterior cortical atrophy.